Epigral Limited
Epigral Limited, a prominent player in the biotechnology sector, is headquartered in India and operates extensively across various regions. Founded in 2015, the company has rapidly established itself as a leader in the development of innovative solutions for the pharmaceutical and healthcare industries. Specialising in advanced drug delivery systems and biopharmaceuticals, Epigral Limited is recognised for its unique approach to enhancing therapeutic efficacy and patient compliance. The company’s commitment to research and development has led to significant milestones, including collaborations with major healthcare institutions. With a strong market position, Epigral Limited continues to drive advancements in biotechnology, making substantial contributions to the global healthcare landscape. Its focus on quality and innovation sets it apart in a competitive industry, ensuring it remains at the forefront of biotechnological advancements.
DitchCarbon Score
How does Epigral Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Salt and Mineral Mining industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Epigral Limited's score of 12 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Epigral Limited's reported carbon emissions
In 2023, Epigral Limited reported significant carbon emissions, with Scope 1 emissions totalling approximately 1,068,775,820 kg CO2e and Scope 2 emissions at about 80,113,000 kg CO2e. The combined total for these two scopes reached approximately 1,148,888,820 kg CO2e. For the previous year, 2024, the company recorded Scope 1 emissions of about 1,150,906,590 kg CO2e, Scope 2 emissions of approximately 61,263,810 kg CO2e, and Scope 3 emissions of about 35,898,630 kg CO2e, bringing the total emissions to around 1,248,069,030 kg CO2e. Despite these figures, there are currently no disclosed reduction targets or climate pledges from Epigral Limited. The absence of specific initiatives or commitments indicates a potential area for improvement in their climate strategy. The company’s emissions intensity metrics suggest a focus on reducing emissions relative to revenue, with values of 0.000525 for 2023 and 0.014376 for 2024, indicating a need for enhanced sustainability practices moving forward.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 1,068,775,820 | 0,000,000,000 |
| Scope 2 | 80,113,000 | 00,000,000 |
| Scope 3 | - | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Epigral Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
